Induction of apoptosis by curcumin and its implications for cancer therapy

Current Cancer Drug Targets

Volumn 5, Issue 2, 2005, Pages 117-129

  Karunagaran, D ^a   Rashmi, R ^a   Santhosh Kumar, T R ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

Antisense; Apoptosis; Bcl 2; Bel XL; Cancer; Curcumin; Hsp 70; Ku70

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CISPLATIN; CURCUMIN; FLUOROURACIL; GLUTATHIONE DERIVATIVE; PACLITAXEL; PIPERINE; VINBLASTINE; VINCRISTINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CANCER RESISTANCE; CELL DEATH; CHEMOPROPHYLAXIS; CURCUMA LONGA; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; GENE MUTATION; HUMAN; HUMAN CELL; MITOCHONDRION; MITOSIS INHIBITION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; THYMOCYTE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CURCUMIN; HUMANS; NEOPLASMS;

EID: 16844371915     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009053202081     Document Type: Review

References (147)

1. Araujo, C. C.; Leon, L. L. Biological activities of Curcuma longa L. Mem. Inst. Oswaldo Cruz. 2001, 96, 723-728.
2. Ammon, H. P.; Wahl, M. A. Pharmacology of Curcuma longa. Planta. Med. 1991, 57, 1-7.
3. Chattopadhyay, I.; Biswas, K.; Bandyopadhyay, U.; Banerjee, R. K. Turmeric and curcumin: Biological actions and medicinal applications. Curr. Set. 2004, 87, 44-53.
4. Charles, V.; Charles, S. X. The use and efficacy of Azadirachta indica ADR ('Neem') and Curcuma longa ('Turmeric') in scabies. A pilot study. Trop. Geogr. Med. 1992, 44, 178-181.
5. Srimal, R. C.; Dhawan, B. N. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 1973, 25, 447-452.
6. Ruby, A. J.; Kuttan, G.; Babu, K. D.; Rajasekharan, K. N.; Kuttan, R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett. 1995, 94, 79-83.
7. Rao, T. S.; Basu, N.; Siddiqui, H. H. Anti-inflammatory activity of curcumin analogues. Indian J. Med. Res. 1982, 75, 574-578.
8. Miquel, J.; Bernd, A.; Sempere, J. M.; Diaz-Alperi, J.; Ramirez, A. The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch. Gerontol. Geriatr. 2002, 34, 37-46.
9. Huang, M. T.; Smart, R. C.; Wong, C. Q.; Conney, A. H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 1988, 48, 5941-5946.
10. Huang, M. T.; Lou, Y. R.; Ma, W.; Newmark, H. L.; Reuhl, K. R.; Conney, A. H. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 1994, 54, 5841-5847.
11. Kelloff, G. J.; Boone, C. W.; Crowell, J. A.; Steele, V. E.; Lubet, R.; Sigman, C. C. Chemopreventive drug development: perspectives and progress. Cancer Epidemiol. Biomarkers Prev. 1994, 3, 85-98.
12. Joe, B.; Vijaykumar, M.; Lokesh, B. R. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr. 2004, 44, 97-111.
13. Igney, F. H.; Krammer, P. H. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2002, 2, 277-288.
14. Johnstone, R. W.; Ruefli, A. A.; Lowe, S. W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002, 108, 153-164.
15. Lowe, S. W.; Lin, A. W. Apoptosis in cancer. Carcinogenesis 2000, 21, 485-495.
16. Nagata, S. Apoptosis by death factor. Cell 1997, 88, 355-365.
17. Aggarwal, B. B.; Kumar, A.; Bharti, A. C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003, 23, 363-398.
18. Chainani-Wu, N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J. Altern. Complement. Med. 2003, 9, 161-168.
19. Leu, T. H.; Maa, M. C. The molecular mechanisms for the antitumorigenic effect of curcumin. Curr. Med. Chem. Anti-Cancer Agents 2002, 2, 357-370.
20. Li, J. K.; Lin-Shia, S. Y. Mechanisms of cancer chemoprevention by curcumin. Proc. Natl. Sci. Counc. Repub. China B 2001, 25, 59-66.
21. Huang, M. T.; Newmark, H. L.; Frenkel, K. Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell. Biochem. Suppl. 1997, 27, 26-34.
22. Wang, Y. J.; Pan, M. H.; Cheng, A. L.; Lin, L. I.; Ho, Y. S.; Hsieh, C. Y.; Lin, J. K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 1997, 15, 1867-1876.
23. Ravindranath, V.; Chandrasekhara, N. Absorption and tissue distribution of curcumin in rats. Toxicology 1980, 16, 259-265.
24. Ravindranath, V.; Chandrasekhara, N. Metabolism of curcumin-studies with [3H]curcumin. Toxicology 1981, 22, 337-344.
25. Ireson, C.; Orr, S.; Jones, D. J.; Verschoyle, R.; Lim, C. K.; Luo, J. L.; Howells, L.; Plummer, S.; Jukes, R.; Williams, M.; Steward, W. P.; Gescher, A. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 2001, 61, 1058-1064.
26. Shoba, G.; Joy, D.; Joseph, T.; Majeed, M.; Rajendran, R.; Srinivas, P. S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998, 64, 353-356.
27. Wu, Y.; Chen, Y.; He, M. The influence of curcumin on the cell cycle of HL-60 cells and contrast study. J. Tongji Med. Univ. 2000, 20, 123-125.
28. Bharti, A. C.; Donate, N.; Singh, S.; Aggarwal, B. B. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003, 104, 1053-1062.
29. Wu, Y.; Chen, Y.; Xu, J.; Lu, L. Anticancer activities of curcumin on human Burkitt's lymphoma. Zhonghua Zhong Liu Za Zhi 2002, 24, 348-352.
30. Aggarwal, S.; Takada, Y.; Singh, S.; Myers, J. N.; Aggarwal, B. B. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int. J. Cancer 2004, 111, 679-692.
31. Jaiswal, A. S.; Marlow, B. P.; Gupta, N.; Narayan, S. Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogens 2002, 21, 8414-8427.
32. Moragoda, L.; Jaszewski, R.; Majumdar, A. P. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res. 2001, 21, 873-878.
33. Hanif, R.; Qiao, L.; Shift, S. J.; Rigas, B. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. J. Lab. Clin. Med. 1997, 130, 576-584.
34. Chen, Y. C.; Kuo, T. C.; Lin-Shiau, S. Y.; Lin, J. K. Induction of HSP70 gene expression by modulation of Ca(+2) ion and cellular p53 protein by curcumin in colorectal carcinoma cells. Mol. Carcinogenesis 1996, 17, 224-234.
35. Chen, H.; Zhang, Z. S.; Zhang, Y. L.; Zhou, D. Y. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res. 1999, 19, 3675-3680.
36. Singh, A. K.; Sidhu, G. S.; Deepa, T.; Maheshwari, R. K. Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell. Cancer Lett. 1996, 107, 109-115.
37. Park, M. J.; Kim, E. H.; Park, I. C.; Lee, H. C.; Woo, S. H.; Lee, J. Y.; Hong, Y. J.; Rhee, C. H.; Choi, S. H.; Shim, B. S.; Lee, S. H.; Hong, S. I. Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21 WAF1/CIP1, p27KIP1 and p53. Int. J. Oncol. 2002, 21, 379-383.
38. Chen, H. W.; Huang, H. C. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br. J. Pharmacol. 1998, 124, 1029-1040.
39. Batth, B. K.; Tripathi, R.; Srinivas, U. K. Curcumin-induced differentiation of mouse embryonal carcinoma PCC4 cells. Differentiation 2001, 68, 133-140.
40. Ramachandran, C.; You, W. Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res. Treat. 1999, 54, 269-278.
41. Mehta, K.; Pantazis, P.; McQueen, T.; Aggarwal, B. B. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 1997, 8, 470-481.
42. Pan, M. H.; Chang, W. L.; Lin-Shiau, S. Y.; Ho, C. T.; Lin, J. K. Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J. Agric. Food Chem. 2001, 49, 1464-1474.
43. Jiang, M. C., Yang-Yen, H. F.; Yen, J. J.; Lin, J. K. Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr. Cancer 1996, 26, 111-120.
44. Gautam, S. C.; Xu, Y. X.; Pindolia, K. R.; Janakiraman, N.; Chapman, R. A. Nonselective inhibition of proliferation of transformed and nontransformed cells by the anticancer agent curcumin (diferuloylmethane). Biochem. Pharmacol. 1998, 55, 1333-1337.
45. Hong, R. L.; Spohn, W. H.; Hung, M. C. Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin. Cancer Res. 1999, 5, 1884-1891.
46. Khar, A.; Ali, A. M.; Pardhasaradhi, B. V.; Varalakshmi, C. H.; Anjum, R.; Kumari, A. L. Induction of stress response renders human tumor cell lines resistant to curcumin-mediated apoptosis: role of reactive oxygen intermediates. Cell Stress Chaperones 2001, 6, 368-376.
47. Syng-Ai, C.; Kumari, A. L.; Khar, A. Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2. Mol. Cancer Ther. 2004, 3, 1101-1108.
48. Radhakrishna Pillai, G.; Srivastava, A. S.; Hassanein, T. I.; Chauhan, D. P.; Carrier, E. Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett. 2004, 208, 163-170.
49. Tourkina, E.; Gooz, P.; Oates, J. C.; Ludwicka-Bradley, A.; Silver, R. M.; Huffman, S. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am. J. Respir. Cell Mol. Biol. 2004, 31, 28-35.
50. Holy, J. M. Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutat. Res. 2002, 518, 71-84.
51. Ashkenazi, A.; Dixit, V. M. Death receptors: signaling and modulation. Science 1998, 281, 1305-1308.
52. Liu, X.; Kim, C. N.; Yang, J.; Jemmerson, R.; Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996, 86, 147-157.
53. Li, P.; Nijhawan, D.; Budihardjo, I.; Srinivasula, S. M.; Ahmad, M.; Alnemri, E. S.; Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91, 479-489.
54. Zou, H.; Li, Y.; Liu, X.; Wang, X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 1999, 274, 11549-11556.
55. Slee, E. A.; Harte, M. T.; Kluck, R. M.; Wolf, B. B.; Casiano, C. A.; Newmeyer, D. D.; Wang, H. G.; Reed, J. C.; Nicholson, D. W.; Alnemri, E. S.; Green, D. R.; Martin, S. J. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 1999, 144, 281-292.
56. Du, C.; Fang, M.; Li, Y.; Li, L.; Wang, X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000, 102, 33-42.
57. Bielak-Zmijewska, A.; Koronkiewicz, M.; Skierski, J.; Piwocka, K.; Radziszewska, E.; Sikora, E. Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells. Nutr. Cancer 2000, 38, 131-138.
58. Bielak-Mijewska, A.; Piwocka, K.; Magalska, A.; Sikora, E. P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells. Cancer Chemother. Pharmacol. 2004, 53, 179-185.
59. Roy, M.; Chakraborty, S.; Siddiqi, M.; Bhattacharya, R. K. Induction of Apoptosis in Tumor Cells by Natural Phenolic Compounds. Asian Pac. J. Cancer Prev. 2002, 3, 61-67.
60. Chen, Y.; Wu, Y.; He, J.; Chen, W. The experimental and clinical study on the effect of curcumin on cell cycle proteins and regulating proteins of apoptosis in acute myelogenous leukemia. J. Huazhong Univ. Sci. Technol. Med. Sci. 2002, 22, 295-298.
61. Anto, R. J.; Mukhopadhyay, A.; Denning, K.; Aggarwal, B. B. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 2002, 23, 143-150.
62. Collett, G. P.; Campbell, F. C. Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 2004, 25, 2183-2189.
63. Rashmi, R.; Santhosh Kumar, T. R.; Karunagaran, D. Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett. 2003, 538, 19-24.
64. Rashmi, R.; Kumar, S.; Karunagaran, D. Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis. Carcinogenesis 2004, 25, 179-187.
65. Choudhuri, T.; Pal, S.; Agwarwal, M. L.; Das, T.; Sa, G. Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett. 2002, 512, 334-340.
66. Kim, M. S.; Kang, H. J.; Moon, A. Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells. Arch. Pharm. Res. 2001, 24, 349-354.
67. Ramachandran, C.; Fonseca, H. B.; Jhabvala, P.; Escalon, E. A.; Melnick, S. J. Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Lett. 2002, 184, 1-6.
68. Zheng, M.; Ekmekcioglu, S.; Walch, E. T.; Tang, C. H.; Grimm, E. A. Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res 2004, 14, 165-171.
69. Bush, J. A.; Cheung, K. J. Jr.; Li, G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp. Cell Res. 2001, 271, 305-314.
70. Jee, S. H.; Shen, S. C.; Tseng, C. R.; Chiu, H. C.; Kuo, M. L. Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J. Invest. Dermatol. 1998, 111, 656-661.
71. Han, S. S.; Chung, S. T.; Robertson, D. A.; Ranjan, D.; Bondada, S. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin. Immunol. 1999, 93, 152-161.
72. Liontas, A.; Yeger, H. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res. 2004, 24, 987-998.
73. Duvoix, A.; Morceau, F.; Delhalle, S.; Schmitz, M.; Schnekenburger, M.; Galteau, M. M.; Dicato, M.; Diederich, M. Induction of apoptosis by curcumin: mediation by glutathione S-transferase PI-1 inhibition. Biochem. Pharmacol. 2003, 66, 1475-1483.
74. Khar, A.; Ali, A. M.; Pardhasaradhi, B. V.; Begum, Z.; Anjum, R. Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells. FEBS Lett. 1999, 445, 165-168.
75. Bhaumik, S.; Anjum, R.; Rangaraj, N.; Pardhasaradhi, B. V.; Khar, A. Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett. 1999, 456, 311-314.
76. Cipriani, B.; Borsellino, G.; Knowles, H.; Tramonti, D.; Cavaliere, F.; Bernardi, G.; Battistini, L.; Brosnan, C. F. Curcumin inhibits activation of Vgamma9Vdelta2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J. Immunol. 2001, 167, 3454-3462.
77. Woo, J. H.; Kim, Y. H.; Choi, Y. J.; Kim, D. G.; Lee, K. S.; Bae, J. H.; Min do, S.; Chang, J. S.; Jeong, Y. J.; Lee, Y. H.; Park, J. W.; Kwon, T. K. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 2003, 24, 1199-1208.
78. Zheng, L. D.; Tong, Q. S.; Wu, C. H. Inhibitory effects of curcumin on apoptosis of human ovary cancer cell line A2780 and its molecular mechanism. Ai Zheng 2002, 21, 1296-1300.
79. Pal, S.; Choudhuri, T.; Chattopadhyay, S.; Bhattacharya, A.; Datta, G. K.; Das, T.; Sa, G. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells. Biochem. Biophys. Res. Commun. 2001, 288, 658-665.
80. Mukhopadhyay, A.; Bueso-Ramos, C.; Chatterjee, D.; Pantazis, P.; Aggarwal, B. B. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 2001, 20, 7597-7609.
81. Morin, D.; Barthelemy, S.; Zini, R.; Labidalle, S.; Tillement, J. P. Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation. FEBS Lett. 2001, 495, 131-136.
82. Susin, S. A.; Lorenzo, H. K.; Zamzami, N.; Marzo, I.; Snow, B. E.; Brothers, G. M.; Mangion, J.; Jacotot, E.; Costantini, P.; Loeftler, M.; Larochette, N.; Goodlett, D. R.; Aebersold, R.; Siderovski, D. P.; Penninger, J. M.; Kroemer, G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397, 441-446.
83. Li, L. Y.; Luo, X.; Wang, X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001, 412, 95-99.
84. Rashmi, R.; Kumar, S.; Karunagaran, D. Ectopic expression of Bcl-xL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their downregulation potentiates it. Carcinogenesis 2004, 25, 1867-1877.
85. Fujisawa, S.; Atsumi, T.; Ishihara, M.; Kadoma, Y. Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Res. 2004, 24, 563-569.
86. Subramanian, M.; Sreejayan Rao, M. N.; Devasagayam, T. P.; Singh, B. B. Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants. Mutat. Res. 1994, 311, 249-255.
87. Reddy, A. C.; Lokesh, B. R. Effect of dietary turmeric (Curcuma longa) on iron-induced lipid peroxidation in the rat liver. Food Chem. Toxicol. 1994, 32, 279-283.
88. White, E. L., Ross, L. J.; Schmid, S. M.; Kelloff, G. J.; Steele, V. E.; Hill, D. L. Screening of potential cancer preventing chemicals for induction of glutathione in rat liver cells. Oncol. Rep. 1998, 5, 507-512.
89. Ahsan, H.; Parveen, N.; Khan, N. U.; Hadi, S. M. Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem. Biol. Interact. 1999, 121, 161-175.
90. Kuo, M. L.; Huang, T. S.; Lin, J. K. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim. Biophys. Acta 1996, 1317, 95-100.
91. Jaruga, E.; Salvioli, S.; Dobrucki, J., Chrul, S.; Bandorowicz-Pikula, J.; Sikora, E.; Franceschi, C.; Cossarizza, A.; Bartosz, G. Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Lett. 1998, 433, 287-293.
92. Piwocka, K.; Zablocki, K.; Wieckowski, M. R.; Skierski, J.; Feiga, I.; Szopa, J.; Drela, N.; Wojtczak, L., Sikora, E. A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp. Cell Res. 1999, 249, 299-307.
93. Piwocka, K.; Jaruga, E.; Skierski, J.; Gradzka, I.; Sikora, E. Effect of glutathione depletion on caspase-3 independent apoptosis pathway induced by curcumin in Jurkat cells. Free Radic. Biol. Med. 2001, 31, 670-678.
94. Jaruga, E.; Sokal, A.; Chrul, S.; Bartosz, G. Apoptosis-independent alterations in membrane dynamics induced by curcumin. Exp. Cell Res. 1998, 245, 303-312.
95. Somasundaram, S.; Edmund, N. A.; Moore, D. T.; Small, G. W.; Shi, Y. Y.; Orlowski, R. Z. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 2002, 62, 3868-3875.
96. Sikora, E.; Bielak-Zmijewska, A.; Piwocka, K.; Skierski, J.; Radziszewska, E. Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem. Pharmacol. 1997, 54, 899-907.
97. Jaruga, E.; Bielak-Zmijewska, A.; Sikora, E.; Skierski, J.; Radziszewska, E.; Piwocka, K.; Bartosz, G. Glutathione-independent mechanism of apoptosis inhibition by curcumin in rat thymocytes. Biochem. Pharmacol. 1998, 56, 961-965.
98. Sood, A.; Mathew, R.; Trachtman, H, Cytoprotective effect of curcumin in human proximal tubule epithelial cells exposed to shiga toxin. Biochem. Biophys. Res. Commun. 2001, 283, 36-41.
99. Martinou, J. C.; Green, D. R. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell Biol. 2001, 2, 63-67.
100. Korsmeyer, S, J.; Wei, M. C.; Saito, M.; Weiler, S., Oh, K. J.; Schlesinger, P. H. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ. 2000, 7, 1166-1173.
101. Chao, D. T.; Korsmeyer, S. J. BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 1998, 16, 395-419.
102. Li, H.; Zhu, H.; Xu, C. J.; Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94, 491-501.
103. Anjuni, R.; Khar, A. Differential regulation of apoptosis in AK-5 tumor cells by the proto-oncogene Bcl-2: presence of Bcl-2 dependent and independent pathways. FEBS Lett. 2001, 499, 166-170.
104. Hsu, Y. T.; Youle, R. J. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem. 1998, 273, 10777-83.
105. Theodorakis, P.; Lomonosova, E.; Chinnadurai, G. Critical requirement of BAX for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. Cancer Res. 2002, 62, 3373-3376.
106. Yamaguchi, H.; Bhalla, K.; Wang, H. G. Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria. Cancer Res. 2003, 63, 1483-1489.
107. Sawada, M.; Sun, W.; Hayes, P.; Leskov, K.; Boothman, D. A.; Matsuyama, S. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat. Cell Biol. 2003, 5, 320-329.
108. Wilson, C. R.; Davidson, S. E.; Margison, G. P.; Jackson. S. P.; Hendry, J. H.; West, C. M. Expression of Ku70 correlates with survival in carcinoma of the cervix. Br. J. Cancer 2000, 83, 1702-1706.
109. Zhao, H. J.; Hosoi, Y.; Miyachi, H.; Ishii, K.; Yoshida. M.; Nemoto, K.; Takai, Y.; Yamada, S.; Suzuki, N.; Ono, T. DNA-dependent protein kinase activity correlates with Ku70 expression and radiation sensitivity in esophageal cancer cell lines. Clin. Cancer Res. 2000, 6, 1073-1078.
110. Zheng, L. D.; Tong, Q. S.; Tao, K. X.; Wang, L.; Zhang, B. Effects of Smac gene overexpression on chemotherapeutic sensitivity of gastric cancer cell line MKN-45. Ai Zheng 2004, 23, 361-366.
111. Jaattela, M. Escaping cell death: survival proteins in cancer. Exp. Cell Res. 1999, 245, 30-43.
112. Garrido, C.; Gurbuxani, S.; Ravagnan, L.; Kroemer, G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem. Biophys. Res. Commun. 2001, 286, 433-442.
113. Saleh, A.; Srinivasula, S. M.; Balkir, L.; Robbins, P. D.; Alnemri, E. S. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell Biol. 2000, 2, 476-483.
114. Korutla, L.; Kumar, R. Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim. Biophys. Acta 1994, 1224, 597-600.
115. Scott, D. W.; Loo, G. Curcumin-induced GADD153 gene upregulation in human colon cancer cells. Carcinogenesis 2004, 25, 2155-2164.
116. Karin, M.; Cao, Y.; Greten, F. R.; Li, Z. W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2002, 2, 301-310.
117. Anto, R. J.; Maliekal, T. T.; Karunagaran, D. L-929 cells harboring ectopically expressed RelA resist curcumin-induced apoptosis. J. Biol. Chem. 2000, 275, 15601-15604.
118. Bharti, A. C.; Shishodia, S.; Reuben, J. M.; Weber, D.; Alexanian, R.; Raj-Vadhan, S.; Estrov, Z.; Talpaz, M.; Aggarwal, B. B. Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood 2004, 105, 3175-3184.
119. Romashkova, J. A.; Makarov, S. S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999, 401, 86-90.
120. Ozes, O. N.; Mayo, L. D.; Gustin, J. A.; Pfeffer, S. R.; Pfeffer, L. M.; Donner, D. B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999, 401, 82-85.
121. Chaudhary, L. R.; Hruska, K. A. Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J. Cell. Biochem. 2003, 59, 1-5.
122. Zheng, S.; Chen, A. Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cell in vitro. Biochem. J. 2004, 384, 149-157.
123. Onoda, M.; Inano, H. Effect of curcumin on the production of nitric oxide by cultured rat mammary gland. Nitric Oxide 2000, 4, 505-515.
124. Chan, M. M.; Huang, H. I.; Fenton, M. R.; Fong, D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem. Pharmacol. 1998, 55, 1955-1962.
125. Hahn, W. C.; Stewart, S. A.; Brooks, M. W.; York, S. G.; Eaton, E.; Kurachi, A.; Beijersbergen, R. L.; Knoll, J. H.; Meyerson, M.; Weinberg, R. A. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 1999, 5, 1164-1170.
126. Zhang, X.; Mar, V.; Zhou, W.; Harrington, L.; Robinson, M. O. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 1999, 13, 2388-2399.
127. Hasmeda, M.; Polya, G. M. Inhibition of cyclic AMP-dependent protein kinase by curcumin. Phytochemistry 1996, 42, 599-605.
128. Huang, M. T.; Lysz, T.; Ferraro, T.; Abidi, T. F.; Laskin, J. D.; Conney, A. H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 1991, 51, 813-819.
129. Hour, T. C.; Chen, J.; Huang, C. Y.; Guan, J. Y.; Lu, S. H.; Pu, Y. S. Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation. Prostate 2002, 51, 211-218.
130. Deeb, D.; Xu, Y. X.; Jiang, H.; Gao, X.; Janakiraman, N.; Chapman, R. A.; Gautam, S. C. Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Mol. Cancer Ther. 2003, 2, 95-103.
131. Deeb, D.; Jiang, H.; Gao, X.; Hafner, M. S.; Wong, H.; Divine, G.; Chapman, R. A.; Dulchavsky, S. A.; Gautam, S. C. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol. Cancer Ther. 2004, 3, 803-812.
132. Chan, M. M.; Fong, D., Soprano, K. J.; Holmes, W. F.; Heverling, H. Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J. Cell Physiol. 2003, 194, 63-70.
133. Koo, J. Y.; Kim, H. J.; Jung, K. O.; Park, K. Y. Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil. J. Med. Food 2004, 7, 117-121.
134. Chuang, S. E.; Yeh, P. Y.; Lu, Y. S.; Lai, G. M; Liao, C. M.; Gao, M.; Cheng, A. L. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem. Pharmacol. 2002, 63, 1709-1716.
135. Limtrakul, P.; Anuchapreeda, S.; Buddhasukh, D. Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 2004, 4, 13.
136. Spingarn, A.; Sacks, P. G.; Kelley, D.; Dannenberg, A. J.; Schantz, S. P. Synergistic effects of 13-cis retinoic acid and arachidonic acid cascade inhibitors on growth of head and neck squamous cell carcinoma in vitro. Otolaryngol Head Neck Surg. 1998, 118, 159-164.
137. Liu, Y.; Chang, R. L.; Cui, X. X.; Newmark, H. L.; Conney, A. H. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells. Oncol. Res. 1997, 9, 19-29.
138. Chendil, D.; Ranga, R. S.; Meigooni, D.; Sathishkumar, S.; Ahmed, M. M. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 2004, 23, 1599-1607.
139. Chen, H. W.; Yu, S. L.; Chen, J. J.; Li, H. N.; Lin, Y. C.; Yao, P. L.; Chou, H. Y.; Chien, C. T.; Chen, W. J.; Lee, Y. T.; Yang, P. C. Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol. Pharmacol. 2004, 65, 99-110.
140. Van Erk, M. J.; Teuling, E.; Staal, Y. C.; Huybers, S.; Van Bladeren, P. J.; Aarts, J. M.; Van Ommen, B, Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells. J. Carcinog. 2004, 3, 8.
141. Sharma, R. A.; McLelland, H. R.; Hill, K. A.; Ireson, C. R.; Euden, S. A.; Manson, M. M.; Pirmohamed, M.; Marnett, L, J.; Gescher, A. J.; Steward, W. P. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 2001, 7, 1894-1900.
142. Lal, B.; Kapoor, A. K.; Agrawal, P. K.; Asthana, O. P.; Srimal, R. C. Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother. Res. 2000, 14, 443-447.
143. Cheng, A. L.; Hsu, C. H.; Lin, J. K.; Hsu, M. M.; Ho, Y. F.; Shen, T. S.; Ko, J. Y.; Lin, J. T.; Lin, B. R.; Ming-Shiang, W.; Yu, H. S.; Jee, S. H.; Chen, G. S.; Chen, T. M.; Chen, C. A.; Lai, M. K.; Pu, Y. S.; Pan, M. H.; Wang, Y. J.; Tsai, C. C.; Hsieh, C. Y. Phase 1 clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21, 2895-2900.
144. Blagosklonny, M. V. Cell death beyond apoptosis. Leukemia 2000, 14, 1502-1508.
145. Leist, M.; Jaattela, M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2001, 2, 589-598.
146. Broker, L. E.; Huisman, C.; Span, S. W.; Rodriguez, J. A.; Kruyt, F. A.; Giaccone, G. Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res. 2004, 64, 27-30.
147. Foghsgaard, L.; Wissing, D.; Mauch, D.; Lademann, U.; Bastholm, L.; Boes, M.; Elling, F.; Leist, M.; Jaattela, M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 2001, 153, 999-1010.